Orpea has published sales of 1,346 million euros (unaudited) for the 4th quarter, up +11.7% on the same period a year earlier, including +9.7% organic growth.
The Group's business activity is on the rise, with an average occupancy rate of 84% in Q4 2023, up +1.9 points on Q4 2022.
For the full year, consolidated sales amount to 5198 million euros (unaudited figure), up +11% on 2022, of which +9.5% on an organic basis.
The average occupancy rate in 2023 will be +1.5 pt higher than in 2022.
The Company adds that EBITDAR and pre-IFRS 16 EBITDA for 2023 are expected to come in at around €690 million and €200 million respectively, less than 5% behind the estimate.
Lastly, following the €390 million rights issue completed on February 15, the Group wishes to remind its shareholders that between February 20 and March 21, 2024, the Company will carry out a reverse stock-split.
Specifically, 1,000 existing shares with a par value of E0.01 each will be exchanged for one new share with a par value of E10.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
ORPEA is the European leader in global dependency care. The group operates retirement homes, follow-up care clinics, and psychiatric clinics.
At the end of 2022, ORPEA had a network of 992 facilities (90,860 beds) located in France (358 facilities; 33,462 beds), Benelux/the United Kingdom/Ireland (193 facilities; 10,708 beds), Central Europe (237 facilities; 23,765 beds), Eastern Europe (124 facilities; 12,764 beds), the Iberian Peninsula and Latin America (79 facilities; 10,007 beds) and China (1 facility; 154 beds)
The group has a real estate portfolio of nearly 2.3 million m2 with a value of EUR 6,500 million.
Net sales are distributed geographically as follows: France/Benelux/the United Kingdom/Ireland (59.9%), Central Europe (25.6%), Eastern Europe (9.3%), Iberian Peninsula and Latin America (5.1%) and other (0.1%).
ORPEA 
